# Drug-Drug Interaction Study of Voriconazole With Clarithromycin.

> **NCT05380245** · PHASE4 · COMPLETED · sponsor: **Abdul Wali Khan University Mardan** · enrollment: 12 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** Voriconazole 200 mg x 2 Tablets
- **DRUG:** Clarithromycin 500 mg x 1Tablets

## Key facts

- **NCT ID:** NCT05380245
- **Lead sponsor:** Abdul Wali Khan University Mardan
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-11-01
- **Primary completion:** 2018-11-16
- **Final completion:** 2018-11-30
- **Target enrollment:** 12 (ACTUAL)
- **Last updated:** 2022-05-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05380245

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05380245, "Drug-Drug Interaction Study of Voriconazole With Clarithromycin.". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT05380245. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*